Bayer HealthCare’s Grants4Apps® Accelerator program in 2014, applications for 2015 are now available for health tech startups in Canada: a CATA partnered opportunity
April 21, 2015


News Release

Bayer Inc.
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6 (905) 282-5550
www.bayer.ca

Bayer HealthCare's Grants4Apps® Accelerator invites Canadian health tech startups to submit their innovative healthcare projects

TORONTO, ON, April, 20, 2015 – Following the successful first year of Bayer HealthCare’s Grants4Apps® Accelerator program in 2014, applications for 2015 are now available for health tech startups in Canada.

The open innovation program welcomes startups whose software services, hardware, technologies, or apps have the potential of creating value for physicians and patients. Selected startups will receive mentoring by entrepreneurs and Bayer experts, office space for 100 days at Bayer Pharma AG headquarters, and funding of €50,000.

“Innovative approaches through technology are key to transforming the health care sector to make the industry more efficient and accessible,” says Christian Lauterbach, President & CEO, Bayer Inc. “Innovation is the foundation to our success and we want to support and share our expertise with Canadian tech startups looking to take their inventive health solutions to the next level.”

Startups that benefited from the program last year include Cortrium with their C3 device, a state-of-the-art wearable tech sensor for wireless monitoring of health data; PharmaAssistant, a self-management tool for chronic disease patients and FabUlyzer, a wearable device that smells your breath to provide a personalized indication of your fat-burn during and after activities.

Projects can be submitted online until May 31, 2015.

For more information on the Grants4Apps® Accerlator program, including the application form, visit: https://www.grants4apps.com/accelerator/

About Bayer in Canada

Bayer Inc. is a Canadian subsidiary of Bayer AG and the corporate headquarters for the Canadian operations. Founded in 1863, Bayer AG is an international research-based group with core businesses in healthcare, crop science and innovative materials committed to creating a better life for all through science.

In Canada, Bayer operates its healthcare business – Pharmaceuticals, Consumer Care, Diabetes
Care, Animal Health and Radiology & Interventional – from its headquarters in Toronto, ON, and
Bayer CropScience Inc. operates out of its head office in Calgary, AB. Together with its material
science business, Bayer improves the quality of life for Canadians through products that fight
disease, protect crops and animals, and provide high-performance materials for numerous daily
life uses.

With more than 1,400 employees across the country, in 2014, Bayer had sales of $1.9 billion and
invested $96 million in research and development in Canada. Globally, Bayer AG had sales of
€42.2 billion and invested €3.6 billion in research and development.
For more information about Bayer, please visit www.bayer.ca.


For more information, please contact:
Martha Linton
Bayer Inc.
martha.linton@bayer.com
905-282-5341

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.